Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-29

FDA Approved: VABOMERE — Original Application (Melinta Therapeutics, LLC)

View source ↗

Summary

FDA approved VABOMERE (meropenem-vaborbactam) from Melinta Therapeutics as an original application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VABOMERE (MEROPENEM-VABORBACTAM)

Snippet

ORIG AP for VABOMERE (MEROPENEM-VABORBACTAM)